Lingyi Biology

About:

Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer.

Website: http://www.lingyimed.com/

Top Investors: Matrix Partners China, HongShan, Beijing Huafang Investment, Transfar Capital, Yifeng Capital

Description:

Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.